Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Oct 2020
Historique:
received: 24 01 2020
revised: 12 05 2020
accepted: 13 05 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 15 4 2021
Statut: ppublish

Résumé

Early detection of thrombotic events remains a big medical challenge. Dextran-based submicronic particles bearing Gd(DOTA) groups and functionalized with fucoidan have been produced via a simple and green water-in-oil emulsification/co-crosslinking process. Their capacity to bind to human activated platelets was evidenced in vitro as well as their cytocompatibility with human endothelial cells. The presence of Gd(DOTA) moieties was confirmed by elemental analysis and total reflection X-ray fluorescence (TRXF) spectrometry. Detailed characterization of particles was performed in terms of size distribution, morphology, and relaxation rates. In particular, longitudinal and transversal proton relaxivities were respectively 1.7 and 5.0 times higher than those of DOTAREM. This study highlights their potential as an MRI diagnostic platform for atherothrombosis.

Identifiants

pubmed: 32718599
pii: S0144-8617(20)30631-7
doi: 10.1016/j.carbpol.2020.116457
pii:
doi:

Substances chimiques

Contrast Media 0
Cross-Linking Reagents 0
Dextrans 0
Emulsions 0
Heterocyclic Compounds 0
Heterocyclic Compounds, 1-Ring 0
Macromolecular Substances 0
Organometallic Compounds 0
Polysaccharides 0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 1HTE449DGZ
fucoidan 9072-19-9
gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate 99J2XUF1JT
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116457

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Laura Marcela Forero Ramirez (LM)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93430 Villetaneuse, France; Laboratoire Polymères Biopolymères Surfaces, CNRS UMR 6270 & FR3038, Normandie Université, Université de Rouen, INSA de Rouen, F-76821 Mont Saint Aignan, France.

Elise Gobin (E)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93430 Villetaneuse, France.

Rachida Aid-Launais (R)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; UMS34 FRIM, X. Bichat Medical School, Université de Paris, F-75018 Paris, France.

Clément Journe (C)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; UMS34 FRIM, X. Bichat Medical School, Université de Paris, F-75018 Paris, France.

Fernanda C Moraes (FC)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93430 Villetaneuse, France.

Luc Picton (L)

Laboratoire Polymères Biopolymères Surfaces, CNRS UMR 6270 & FR3038, Normandie Université, Université de Rouen, INSA de Rouen, F-76821 Mont Saint Aignan, France.

Didier Le Cerf (D)

Laboratoire Polymères Biopolymères Surfaces, CNRS UMR 6270 & FR3038, Normandie Université, Université de Rouen, INSA de Rouen, F-76821 Mont Saint Aignan, France.

Didier Letourneur (D)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93430 Villetaneuse, France.

Cédric Chauvierre (C)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France.

Frédéric Chaubet (F)

Laboratory for Vascular Translational Science, UMRS1148, INSERM, Université de Paris, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93430 Villetaneuse, France. Electronic address: frederic.chaubet@univ-paris13.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH